Items tagged with Treatment

WHO position statement on the use of delamanid for MDR-TB (post with simple image)

The World Health Organization issues a position statement on the use of delamanid for multidrug-resistant TB following an expedited review of phase III clinical trial results.

Advocates call on WHO to consolidate and revise its guidance regarding the treatment for MDR-TB (post with simple image)

TB CAB issues a position statement on the use of bedaquiline as part of the preferred regimen for MDR-TB.

Giorgia Sulis: Delamanid — a broken dream for patients with MDR-TB? (post with simple image)

When the new TB drug delamanid was approved by the European Medicines Agency (EMA) in 2013, it was one of only two new drugs approved for the treatment of multidrug-resistant tuberculosis (MDR-TB) in more than 40 years. Preliminary findings suggested that this new drug could have a promising role for treatment when used with an optimised background regimen (OBR)—results that led to the World Health Organization (WHO) conditionally endorsing the drug in 2014 and providing interim policy guidance.

New guide: Your rights and TB care (post with simple image)

An innovative and important new TB resource – Know Your Rights: Tuberculosis Prevention, Diagnosis, and Treatment Guide.

WHO call for patient data on the treatment of drug-resistant TB (post with simple image)

Public call for individual patient data on treatment of multidrug- and rifampicin-resistant TB.

Indian civil society pushes for government use compulsory license on MDR-TB drugs (post with simple image)

Advocates appeal to the Prime Minister of India to issue a government use compulsory license for bedaquiline and delamanid to encourage generic competition.

New guide to shorter regimen for treating drug-resistant TB (post with simple image)

DR-TB STAT + TAG brief: Is Shorter Better? Understanding the Shorter Regimen For Treating Drug-Resistant Tuberculosis

WHO treatment guidelines for isoniazid-resistant TB (post with simple image)

The World Health Organization issues recommendations on management of isoniazid-resistant TB.

WHO response to STREAM Stage 1 preliminary results (post with simple image)

WHO issues a position statement on the continued use of the shorter MDR-TB regimen following an expedited review of the STREAM Stage 1 preliminary result.

Page 60 of 60 · Total posts: 0

←First 59 60